EUVIMEDEUVIMED entdecken
Crossref

Performance of MammaTyper in Fine Needle Aspiration Cytology, Core Needle Biopsy and Surgical Breast Cancer Samples

Maurizio Pinamonti iD, Daniela Santon iD, Cristina Bottin, Elisa Ober, Clara Rizzardi, Claudia Di Lecce, Fabiola Giudici iD, Jerry Polesel, Fabrizio Zanconati

Cytopathology · 2025

DOI: 10.1111/cyt.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, 2025. Verfasst von Maurizio Pinamonti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Azienda Sanitaria-Universitaria Giuliano-Isontina (ASUGI), Department of Pathology, Trieste, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Cytodiagnosis. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Italian Ministry of Health, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the performance and concordance of the MammaTyper molecular test across cytological, biopsy and surgical samples from breast carcinomas, emphasising the applicability of cytology in molecular subtyping.

Methods

29 breast carcinoma cases, each represented by cytological, biopsy and surgical samples, were retrospectively collected from 2021 to 2025 at the Pathology Unit of Trieste. Subtyping was performed using MammaTyper on all sample types. Concordance between MammaTyper results across different sample types was assessed using Lin's concordance correlation coefficient (CCC), overall concordance rate (OCR) and kappa statistics.

Results

A total of 84 samples from breast carcinoma were analysed, including FNAC, CNB and surgical resection specimens. Molecular subtyping was technically successful in all cases. When comparing IHC and MammaTyper results retrieved in CNBs, we found almost perfect agreement for ER, substantial agreement for PgR and HER2 and moderate agreement for Ki‐67. Concordance rates between cytology and FFPE samples (respectively CNB and surgical specimens) showed excellent agreement for ER (CCC 0.81 and 0.835), good agreement for PgR (0.714 and 0.78), excellent agreement for HER2 (0.855 and 0.854) and moderate agreement for Ki‐67 (0.626 and 0.643). In particular, discrepancies in HER2 and Ki‐67 status between cytological and FFPE samples were observed in a relevant subset of cases, potentially affecting therapeutic stratification.

Conclusions

MammaTyper demonstrated high concordance and reliability on cytological and biopsy samples, supporting its use in minimally invasive diagnostics. Despite the discrepancies in some markers, cytology offers a cost‐effective, less invasive alternative to biopsies for molecular subtyping, aligning with precision medicine goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCytodiagnosisHumansFemaleBiopsy, Large-Core NeedleBiopsy, Fine-NeedleMiddle AgedRetrospective StudiesAdultAgedErb-b2 Receptor Tyrosine KinasesBiomarkers, Tumor

Stichwörter der Autor:innen

ErbB‐2biomarkersbreast neoplasmsfine‐needle aspirationgene expression profilingreverse transcriptase polymerase chain reaction

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Azienda Sanitaria-Universitaria Giuliano-Isontina (ASUGI), Department of Pathology, Trieste, Italy.
  • Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • School of Specialization of Pathology, University of Udine, Udine, Italy.
  • Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

ORCID-Profile: Maurizio Pinamonti, Daniela Santon, Fabiola Giudici

Förderung

  • Italian Ministry of Health
  • Ministero della Salute

Zitieren

APA

Pinamonti, M., Santon, D., Bottin, C., Ober, E., Rizzardi, C., Di Lecce, C., Giudici, F., Polesel, J., & Zanconati, F. (2025). Performance of MammaTyper in Fine Needle Aspiration Cytology, Core Needle Biopsy and Surgical Breast Cancer Samples. Cytopathology. https://doi.org/10.1111/cyt.70026

Vancouver

Pinamonti M, Santon D, Bottin C, Ober E, Rizzardi C, Di Lecce C, et al. Performance of MammaTyper in Fine Needle Aspiration Cytology, Core Needle Biopsy and Surgical Breast Cancer Samples. Cytopathology. 2025. doi:10.1111/cyt.70026

BibTeX
@article{Pinamonti2025,
  author = {Pinamonti, Maurizio and Santon, Daniela and Bottin, Cristina and Ober, Elisa and Rizzardi, Clara and Di Lecce, Claudia and Giudici, Fabiola and Polesel, Jerry and Zanconati, Fabrizio},
  title = {Performance of MammaTyper in Fine Needle Aspiration Cytology, Core Needle Biopsy and Surgical Breast Cancer Samples},
  journal = {Cytopathology},
  year = {2025},
  doi = {10.1111/cyt.70026}
}
Kostenlos starten →